Therapeutic stratégies based on glucagon-like peptide 1DEACON, Carolyn F.Diabetes (New York, NY). 2004, Vol 53, Num 9, pp 2181-2189, issn 0012-1797, 9 p.Article

Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safetyDEACON, Carolyn F; HOLST, Jens J.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 15, pp 2047-2058, issn 1465-6566, 12 p.Article

GLP-1-(9-36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretionDEACON, Carolyn F; PLAMBOECK, Astrid; MØLLER, Søren et al.American journal of physiology. Endocrinology and metabolism. 2002, Vol 45, Num 4, pp E873-E879, issn 0193-1849Article

The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in miceROLIN, Bidda; DEACON, Carolyn F; CARR, Richard D et al.European journal of pharmacology. 2004, Vol 494, Num 2-3, pp 283-288, issn 0014-2999, 6 p.Article

What do we know about the secretion and degradation of incretin hormones?DEACON, Carolyn F.Regulatory peptides. 2005, Vol 128, Num 2, pp 117-124, issn 0167-0115, 8 p.Conference Paper

I NCRETI N HORMONE SECRETION OVER THE DAYAHREN, Bo; CARR, Richard D; DEACON, Carolyn F et al.Vitamins and hormones. 2010, Vol 84, pp 203-220, issn 0083-6729, 18 p.Article

Effects of Sitagliptin and Metformin Treatment on Incretin Hormone and Insulin Secretory Responses to Oral and Isoglycemic Intravenous GlucoseVARDARLI, Irfan; ARNDT, Elisabeth; DEACON, Carolyn F et al.Diabetes (New York, NY). 2014, Vol 63, Num 2, pp 663-674, issn 0012-1797, 12 p.Article

Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetesTREMBLAY, André J; LAMARCHE, Benoît; DEACON, Carolyn F et al.Metabolism, clinical and experimental. 2014, Vol 63, Num 9, pp 1141-1148, issn 0026-0495, 8 p.Article

Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humansSNYDER, Eric M; CARR, Richard D; DEACON, Carolyn F et al.Applied physiology, nutrition and metabolism. 2008, Vol 33, Num 5, pp 929-935, issn 1715-5312, 7 p.Article

Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigsDEACON, Carolyn F; DANIELSEN, Patricia; KLARSKOV, Letty et al.Diabetes (New York, NY). 2001, Vol 50, Num 7, pp 1588-1597, issn 0012-1797Article

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patientsVILSBØLL, Tina; KRARUP, Thure; DEACON, Carolyn F et al.Diabetes (New York, NY). 2001, Vol 50, Num 3, pp 609-613, issn 0012-1797Article

Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptideDEACON, Carolyn F; NAUCK, Michael A; MEIER, Juris et al.The Journal of clinical endocrinology and metabolism. 2000, Vol 85, Num 10, pp 3575-3581, issn 0021-972XArticle

Differential regional metabolism of glucagon in anesthetized pigsDEACON, Carolyn F; KELSTRUP, Mette; TREBBIEN, Ramona et al.American journal of physiology. Endocrinology and metabolism. 2003, Vol 48, Num 3, pp E552-E560, issn 0193-1849Article

Incretin Hormone and Insulin Responses to Oral Versus Intravenous Lipid Administration in HumansLINDGREN, Ola; CARR, Richard D; DEACON, Carolyn F et al.The Journal of clinical endocrinology and metabolism. 2011, Vol 96, Num 8, pp 2519-2524, issn 0021-972X, 6 p.Article

Inhibition of DPP-4 with Vildagliptin Improved Insulin Secretion in Response to Oral as well as Isoglycemic Intravenous Glucose without Numerically Changing the Incretin Effect in Patients with Type 2 DiabetesVARDARLI, Irfan; NAUCK, Michael A; KÖTHE, Lars D et al.The Journal of clinical endocrinology and metabolism. 2011, Vol 96, Num 4, pp 945-954, issn 0021-972X, 10 p.Article

Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?RAALTE, Daniel H. Van; KWA, Kelly A. A; GENUGTEN, Renate E. Van et al.Metabolism, clinical and experimental. 2013, Vol 62, Num 4, pp 568-577, issn 0026-0495, 10 p.Article

Hyperglycemia Acutely Lowers the Postprandial Excursions of Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide in HumansVOLLMER, Kirsten; GARDIWAL, Husai; MENGE, Bjoern A et al.The Journal of clinical endocrinology and metabolism. 2009, Vol 94, Num 4, pp 1379-1385, issn 0021-972X, 7 p.Article

The Dipeptidyl Peptidase-4 Inhibitor Vildagliptin Improves β-Cell Function and Insulin Sensitivity in Subjects With Impaired Fasting GlucoseUTZSCHNEIDER, Kristina M; TONG, Jenny; DEACON, Carolyn F et al.Diabetes care. 2008, Vol 31, Num 1, pp 108-113, issn 0149-5992, 6 p.Article

The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patientsBALAS, Bogdan; BAIG, Muhammad R; CUSI, Kenneth et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 4, pp 1249-1255, issn 0021-972X, 7 p.Article

The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjectsVILSBØLL, Tina; AGERSØ, Henrik; LAURITSEN, Torsten et al.Regulatory peptides. 2006, Vol 137, Num 3, pp 168-172, issn 0167-0115, 5 p.Article

Pancreatic β-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetesASMAR, Meena; HØJBERG, Patricia V; DEACON, Carolyn F et al.Regulatory peptides. 2010, Vol 160, Num 1-3, pp 175-180, issn 0167-0115, 6 p.Article

The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucoseBOCK, Gerlies; MAN, Chiara Dalla; RIZZA, Robert A et al.Clinical endocrinology (Oxford. Print). 2010, Vol 73, Num 2, pp 189-196, issn 0300-0664, 8 p.Article

Differential Islet and Incretin Hormone Responses in Morning Versus Afternoon after Standardized Meal in Healthy MenLINDGREN, Ola; MARI, Andrea; DEACON, Carolyn F et al.The Journal of clinical endocrinology and metabolism. 2009, Vol 94, Num 8, pp 2887-2892, issn 0021-972X, 6 p.Article

Effects of the Dipeptidyl Peptidase-IV Inhibitor Vildagliptin on Incretin Hormones, Islet Function, and Postprandial Glycemia in Subjects With Impaired Glucose ToleranceROSENSTOCK, Julio; FOLEY, James E; RENDELL, Marc et al.Diabetes care. 2008, Vol 31, Num 1, pp 30-35, issn 0149-5992, 6 p.Article

The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes : a double-blind, placebo-controlled crossover studyVELLA, Adrian; BOCK, Gerlies; GIESLER, Paula D et al.Clinical endocrinology (Oxford. Print). 2008, Vol 69, Num 5, pp 737-744, issn 0300-0664, 8 p.Article